Treatment Patterns, Outcomes and Healthcare Resource Utilization of Obstructive Hypertrophic Cardiomyopathy in England
Obstructive HCM is associated with a large clinical and economic burden in England, and this burden increases with higher NYHA class. These findings support the need for new and more effective strategies for the management of HCM.
Authors
- Florence Brellier (ORCID: https://orcid.org/0000-0002-0143-472X)
- Belinda Sandler (ORCID: https://orcid.org/0000-0002-4103-3082)
- M Tome Esteban
- Carla L. Zema
- Teresa Lemmer
- Oksana Kirichek
- Michael Hurst (ORCID: https://orcid.org/0000-0001-9360-0280)
- Faizel Osman (ORCID: https://orcid.org/0000-0002-3962-5118)
- John Houghton
- Ovie Utuama
Institutions
- Bristol-Myers Squibb (Germany) (DE)
- St George's, University of London (GB)
- St George’s University Hospitals NHS Foundation Trust (GB)
- University Hospitals Coventry and Warwickshire NHS Trust (GB)
- University of Warwick (GB)
- Bristol-Myers Squibb (United States) (US)
- St George's Hospital (GB)
- Bristol-Myers Squibb (United Kingdom) (GB)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Bristol-Myers Squibb (Sweden) (SE)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1002/ehf2.15213
- Citations
- 2
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- Bristol-Myers Squibb
- Bristol-Myers Squibb Canada